title: Utility of 18FDG-PET/CT in breast cancer diagnostics--a systematic review.
abstract: 18F-fluorodeoxyglucose-positron emission tomography/computed tomography (18FDG-PET/CT) is a non-invasive method for visualization of focally increased metabolism in the presence of discrete morphological changes. Based on a systematic review of current literature, PET/CT cannot be recommended as a primary diagnostic procedure in breast cancer; but it has the potential to be useful for the detection of distant metastases and for monitoring response to chemotherapy in breast cancer patients. PET/CT should still be regarded as a supplement to conventional diagnostic procedures such as CT and MRI.
authors: Department of Oncology, Odense University Hospital, 5000 Odense, Denmark.
authors: Karina
authors: K
authors: Warning
authors: Malene Grubbe
authors: MG
authors: Hildebrandt
authors: Bent
authors: B
authors: Kristensen
authors: Marianne
authors: M
authors: Ewertz
mesh_terms: D001943:Breast Neoplasms / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D005260:Female; D019788:Fluorodeoxyglucose F18; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000295:instrumentation; D019275:Radiopharmaceuticals; D014057:Tomography, X-Ray Computed / Q000295:instrumentation*; D016896:Treatment Outcome
chemical_list: D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18